Business Context and Reporting Period
This Form 8-K filing by The Clorox Company (CLOROX CO) was submitted on September 15, 2004. The report details the entry into a material definitive agreement involving amendments to the Company's equity compensation plans.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and compensation plan amendments.
Material Changes
The Board of Directors amended two key plans on September 15, 2004:
- Directors' Stock Option Plan (1993): Eliminated annual grants of 3,000 stock options to directors.
- Independent Directors' Stock-Based Compensation Plan: Proposed an increase in the annual deferred stock unit grant value from $10,000 to $35,000 for calendar year 2004, and to $75,000 per calendar year thereafter.
- 1996 Stock Incentive Plan: Restricted accelerated vesting of awards upon a Change of Control or Corporate Transaction. Previously, all awards vested immediately upon such events. Under the new terms, awards granted on or after September 15, 2004, will vest on their normal schedule unless the employee is terminated without cause or resigns for "Good Reason" within two years of the event.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary on operational performance. The primary risk disclosed relates to the change in vesting acceleration provisions, which alters the immediate liquidity of equity awards for employees in the event of a corporate transaction.
Investor Verification Checklist
- Verify the shareholder approval status of the proposed increase in director deferred stock unit grants.
- Confirm the specific definitions of "Good Reason" and "Change of Control" within the amended 1996 Plan.
- Assess the impact of eliminating director stock options on total director compensation packages.